Takeda Scheduled To Ink Nycomed Acquisition For $12.3 Billion
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical is ready to sign an agreement with Nycomed sealing its $12.3 billion acquisition of the Swiss drug maker